Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like OWC Pharmaceutical Research Corp. Issues Chairman's Letter To Shareholders September 14, 2017 Novartis Oncology Head to Retire for Personal Reasons December 14, 2017 Novartis AG Lures Superstar Scientist Away From UCSF August 16, 2017
